Seminars in Hematology

Papers
(The H4-Index of Seminars in Hematology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
CAR T-cell therapy comes of age: Introductory editorial for the special issue70
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial64
Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?57
Extramedullary myeloma in the era of CAR T-cell and bispecific antibody therapies46
Clinical applications of circulating tumor DNA in Hodgkin lymphoma45
Insights from the 12th International Workshop on Waldenstrom's Macroglobulinemia44
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-1939
Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation39
How to set up a clinical research center in Brazil, as an example of a middle-income country31
Epidemiology and etiology of diffuse large B-cell lymphoma29
Lessons learned from the Eµ-TCL1 mouse model of CLL24
Somatic mutations in “benign” blood diseases23
Antibody and immunotherapy in diffuse large B-cell lymphoma18
TET2 mutation as prototypic clonal hematopoiesis lesion15
The future of lymphoma diagnosis, prognosis, and treatment monitoring in countries with limited access to pathology services14
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence14
0.99189114570618